ArticleMolecular therapy oncolytics2020

Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability.

Edward M Kennedy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.